Lombard Odier Asset Management (USA)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-25,000
Closed -$2.17M 250
2019
Q1
$2.17M Buy
+25,000
New +$2.13M 0.18% 125
2018
Q4
Sell
-5,000
Closed -$395K 244
2018
Q3
$395K Buy
+5,000
New +$326K 0.03% 211
2018
Q2
Sell
-88,526
Closed -$3.57M 264
2018
Q1
$3.57M Buy
88,526
+1,795
+2% +$87.6K 0.26% 101
2017
Q4
$4.56M Buy
+86,731
New +$4.63M 0.35% 86
2017
Q3
Sell
-120,000
Closed -$4.24M 222
2017
Q2
$4.24M Buy
120,000
+70,000
+140% +$2.16M 0.34% 89
2017
Q1
$1.18M Sell
50,000
-330,000
-87% -$6.54M 0.11% 158
2016
Q4
$5.08M Buy
+380,000
New +$6.13M 0.64% 58

Other funds holding EXAS

Lombard Odier Asset Management (USA)'s EXAS Position: Q2 2019 in Review

Lombard Odier Asset Management (USA) sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 25,000 shares — an estimated $2.17M sold.

Lombard Odier Asset Management (USA) first reported a position in EXAS in Q4 2016 and held it in 7 quarters. The position peaked at $5.08M in Q4 2016. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 25,000 Exact Sciences shares in Q2 2019, an estimated $2.17M.
  • Lombard Odier Asset Management (USA) first reported a position in Exact Sciences in Q4 2016 and held it in 7 quarters.
  • Lombard Odier Asset Management (USA)'s Exact Sciences position peaked at $5.08M in Q4 2016.
  • 472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2019, filed 14 Aug 2019.